BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15147370)

  • 21. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
    LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
    Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism.
    Mitsui S; Yamaguchi S; Matsuo T; Ishida Y; Okamura H
    Genes Dev; 2001 Apr; 15(8):995-1006. PubMed ID: 11316793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the DBP promoter by PAR proteins and in leukemic cells bearing an E2A/HLF translocation.
    Newcombe K; Glassco T; Mueller C
    Biochem Biophys Res Commun; 1998 Apr; 245(2):633-9. PubMed ID: 9571207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.
    Devaraj PE; Foroni L; Sekhar M; Butler T; Wright F; Mehta A; Samson D; Prentice HG; Hoffbrand AV; Secker-Walker LM
    Leukemia; 1994 Jul; 8(7):1131-8. PubMed ID: 7518549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL.
    Hunger SP; Devaraj PE; Foroni L; Secker-Walker LM; Cleary ML
    Blood; 1994 May; 83(10):2970-7. PubMed ID: 8180393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
    de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
    Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukaemia.
    Hunger SP; Cleary ML
    Semin Cancer Biol; 1993 Dec; 4(6):387-99. PubMed ID: 8142624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell transformation mediated by homodimeric E2A-HLF transcription factors.
    Inukai T; Inaba T; Yoshihara T; Look AT
    Mol Cell Biol; 1997 Mar; 17(3):1417-24. PubMed ID: 9032268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
    Maloney KW; McGavran L; Odom LF; Hunger SP
    Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.
    Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H
    Blood; 1999 May; 93(9):2780-90. PubMed ID: 10216071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors.
    Inukai T; Inaba T; Dang J; Kuribara R; Ozawa K; Miyajima A; Wu W; Look AT; Arinobu Y; Iwasaki H; Akashi K; Kagami K; Goi K; Sugita K; Nakazawa S
    Blood; 2005 Jun; 105(11):4437-44. PubMed ID: 15665112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G; te Kronnie G; Basso G
    Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
    de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
    Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
    Duque-Afonso J; Smith KS; Cleary ML
    PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Severe hypercalcemia complicated in acute lymphoblastic leukemia (ALL) with E2A-HLF fusion gene: report of two cases and literature review].
    Yang J; Zhou X; Wang B; Gao C; Zhang RD; Li B
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):615-8. PubMed ID: 19954622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E4BP4/NFIL3, a PAR-related bZIP factor with many roles.
    Cowell IG
    Bioessays; 2002 Nov; 24(11):1023-9. PubMed ID: 12386933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19.
    Inukai T; Hirose K; Inaba T; Kurosawa H; Hama A; Inada H; Chin M; Nagatoshi Y; Ohtsuka Y; Oda M; Goto H; Endo M; Morimoto A; Imaizumi M; Kawamura N; Miyajima Y; Ohtake M; Miyaji R; Saito M; Tawa A; Yanai F; Goi K; Nakazawa S; Sugita K
    Leukemia; 2007 Feb; 21(2):288-96. PubMed ID: 17183364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CES-2-related transcription factor E4BP4 is an intrinsic regulator of motoneuron growth and survival.
    Junghans D; Chauvet S; Buhler E; Dudley K; Sykes T; Henderson CE
    Development; 2004 Sep; 131(18):4425-34. PubMed ID: 15306565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).
    Panagopoulos I; Micci F; Thorsen J; Haugom L; Tierens A; Ulvmoen A; Heim S
    Cancer Genet; 2012 Dec; 205(12):669-72. PubMed ID: 23181981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.